Publikationen

Publications

Since 2014:

251.
Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA.
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
N Engl J Med. 2018 Feb 1;378(5):439-448.

250.
Wallek S, Senn-Malashonak A, Vogt L, Schmidt K, Bader P, Banzer W.
Impact of the initial fitness level on the effects of a structured exercise therapy during pediatric stem cell transplantation.
Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26851. Epub 2017 Oct 19.1.

249.
Bader P, Kuçi Z, Bakhtiar S, Basu O, Bug G, Dennis M, Greil J, Barta A, Kállay KM, Lang P, Lucchini G, Pol R, Schulz A, Sykora KW, von Luettichau I, Herter-Sprie G, Uddin MA, Jenkin P, Alsultan A, Buechner J, Stein J, Kelemen A, Jarisch A, Soerensen J, Salzmann-Manrique E, Hutter M, Schäfer R, Seifried E, Klingebiel T, Bonig H, Kuçi S.
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
Bone Marrow Transplant. 2018 Jan 29. doi: 10.1038/s41409-018-0102-z. Epub ahead of print

248.
Merker M, Meister MT, Rettinger E, Jarisch A, Soerensen J, Willasch A, Huenecke S, Cappel C, Bremm M, Salzmann-Manrique E, Krenn T, Rossig C, Kremens B, Koscielniak E, Klingebiel T, Bader P.
Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.
Bone Marrow Transplant. 2018 Jan 24. doi: 10.1038/s41409-018-0088-6. Epub ahead of print No abstract available.

247.
Kuhlen M, Willasch AM, Dalle JH, Wachowiak J, Yaniv I, Ifversen M, Sedlacek P, Guengoer T, Lang P, Bader P, Sufliarska S, Balduzzi A, Strahm B, von Luettichau I, Hoell JI, Borkhardt A, Klingebiel T, Schrappe M, von Stackelberg A, Glogova E, Poetschger U, Meisel R, Peters C.
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial.
Br J Haematol. 2018 Jan;180(1):82-89.

246.
Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, Burman J, Moore J, Rovira M, Wulffraat NM, Kazmi M, Greco R, Snarski E, Kozak T, Kirgizov K, Alexander T, Bader P, Saccardi R, Farge D.
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.
Blood Adv. 2017 Dec 20;1(27):2742-2755.

245.
Paviglianiti A, Dalle JH, Ayas M, Boelens JJ, Volt F, Iori AP, de Souza MP, Diaz MA, Michel G, Locatelli F, Jubert C, Yakoub-Agha I, Bittencourt H, Bertrand Y, Kenzey C, Maio KT, Hayashi H, Rocha V, Bader P, Gluckman E, Ruggeri A.
Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party.
Biol Blood Marrow Transplant. 2017 Dec 27. pii: S1083-8791(17)31818-9. doi: 10.1016/j.bbmt.2017.12.790. Epub ahead of print

244.
Mainardi C, Ebinger M, Enkel S, Feuchtinger T, Teltschik HM, Eyrich M, Schumm M, Rabsteyn A, Schlegel P, Seitz C, Schwarze CP, Müller I, Greil J, Bader P, Schlegel PG, Martin D, Holzer U, Döring M, Handgretinger R, Lang P.
CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation.
Br J Haematol. 2018 Jan;180(1):90-99.

243.
Chabannon C, Kuball J, Mcgrath E, Bader P, Dufour C, Lankester A, Basak GW, Montoto S, Nagler A, Snowden JA, Styczynski J, Duarte RF, Kröger N, Mohty M.
CAR-T cells: the narrow path between hope and bankruptcy?
Bone Marrow Transplant. 2017 Dec;52(12):1588-1589.

242.
Gastine S, Lehrnbecher T, Müller C, Farowski F, Bader P, Ullmann-Moskovits J, Cornely OA, Groll AH, Hempel G.
Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.
Antimicrob Agents Chemother. 2017 Dec 21;62(1).

241.
Shouval R, Ruggeri A, Labopin M, Mohty M, Sanz G, Michel G, Kuball J, Chevallier P, Al-Seraihy A, Milpied NJ, de Heredia CD, Arcese W, Blaise D, Rocha V, Fein J, Unger R, Baron F, Bader P, Gluckman E, Nagler A.
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia.
Clin Cancer Res. 2017 Nov 1;23(21):6478-6486.

240.
Merker M, Pfirrmann V, Oelsner S, Fulda S, Klingebiel T, Wels WS, Bader P, Rettinger E.
Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.
Oncotarget. 2017 Aug 2;8(39):66137-66153.

239.
Wagner J, Pfannenstiel V, Waldmann A, Bergs JWJ, Brill B, Huenecke S, Klingebiel T, Rödel F, Buchholz CJ, Wels WS, Bader P, Ullrich E.
A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma.
Front Immunol. 2017 Jun 12;8:676. doi: 10.3389/fimmu.2017.00676. eCollection 2017.

238.
Weber V, Radeloff D, Reimers B, Salzmann-Manrique E, Bader P, Schwabe D, Königs C.
Neurocognitive development in HIV-positive children is correlated with plasma viral loads in early childhood.
Medicine (Baltimore). 2017 Jun;96(23):e6867.

237.
Diesch T, Rovo A, von der Weid N, Faraci M, Pillon M, Dalissier A, Dalle JH, Bader P.
Fertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based survey.
Bone Marrow Transplant. 2017 Jul;52(7):1022-1028.

236.
Balduzzi A, Dalle JH, Jahnukainen K, von Wolff M, Lucchini G, Ifversen M, Macklon KT, Poirot C, Diesch T, Jarisch A, Bresters D, Yaniv I, Gibson B, Willasch AM, Fadini R, Ferrari L, Lawitschka A, Ahler A, Sänger N, Corbacioglu S, Ansari M, Moffat R, Dalissier A, Beohou E, Sedlacek P, Lankester A, De Heredia Rubio CD, Vettenranta K, Wachowiak J, Yesilipek A, Trigoso E, Klingebiel T, Peters C, Bader P.
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.
Bone Marrow Transplant. 2017 Oct;52(10):1406-1415.

235.
Uppugunduri CRS, Storelli F, Mlakar V, Huezo-Diaz Curtis P, Rezgui A, Théorêt Y, Marino D, Doffey-Lazeyras F, Chalandon Y, Bader P, Daali Y, Bittencourt H, Krajinovic M, Ansari M.
The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
Front Pharmacol. 2017 Jul 11;8:451.

234.
Bug G, Burchert A, Wagner EM, Kröger N, Berg T, Güller S, Metzelder SK, Wolf A, Hünecke S, Bader P, Schetelig J, Serve H, Ottmann OG.
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial).
Leukemia. 2017 Nov;31(11):2523-2525.

233.
Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P.
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.
Bone Marrow Transplant. 2018 Feb;53(2):138-145.

232.
Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kröger N, Kuball J, Lanza F, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M.
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
Bone Marrow Transplant. 2017 Jun;52(6):811-817.

231.
Yeates L, Slatter MA, Bonanomi S, Lim FLWI, Ong SY, Dalissier A, Barberi W, Shulz A, Duval M, Heilmann C, Willekens A, Hwang WHY, Uderzo C, Bader P, Gennery AR.
Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation.
Bone Marrow Transplant. 2017 May;52(5):762-764.

230.
Page KM, Labopin M, Ruggeri A, Michel G, Diaz de Heredia C, O'Brien T, Picardi A, Ayas M, Bittencourt H, Vora AJ, Troy J, Bonfim C, Volt F, Gluckman E, Bader P, Kurtzberg J, Rocha V; Duke University; Committee- Cellular Therapy, Immunobiology Working Party (CBC-CTIWP); Paediatric Disease Working Party (PDWP) of EBMT, Eurocord.
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.
Biol Blood Marrow Transplant. 2017 Aug;23(8):1350-1358.

229.
Simonin M, Dalissier A, Labopin M, Willasch A, Zecca M, Mouhab A, Chybicka A, Balduzzi A, Volin L, Peters C, Bader P, Dalle JH.
More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party.
Bone Marrow Transplant. 2017 Jul;52(7):1071-1073.

228.
Burman J, Kirgizov K, Carlson K, Badoglio M, Mancardi GL, De Luca G, Casanova B, Ouyang J, Bembeeva R, Haas J, Bader P, Snowden J, Farge D. Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2017 Aug;52(8):1133-1137.

227.
Dalle JH, Lucchini G, Balduzzi A, Ifversen M, Jahnukainen K, Macklon KT, Ahler A, Jarisch A, Ansari M, Beohou E, Bresters D, Corbacioglu S, Dalissier A, Diaz de Heredia Rubio C, Diesch T, Gibson B, Klingebiel T, Lankester A, Lawitschka A, Moffat R, Peters C, Poirot C, Saenger N, Sedlacek P, Trigoso E, Vettenranta K, Wachowiak J, Willasch A, von Wolff M, Yaniv I, Yesilipek A, Bader P.
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015.
Bone Marrow Transplant. 2017 Jul;52(7):1029-1035.

226.
Bakhtiar S, Gámez-Díaz L, Jarisch A, Soerensen J, Grimbacher B, Belohradsky B, Keller KM, Rietschel C, Klingebiel T, Koletzko S, Albert MH, Bader P. Treatment of Infantile Inflammatory Bowel Disease and Autoimmunity by Allogeneic Stem Cell Transplantation in LPS-Responsive Beige-Like Anchor Deficiency.
Front Immunol. 2017 Jan 31;8:52.

225.
De Giorgi U, Nicolas-Virelizier E, Badoglio M, Bader P, Richard S, Maertens J, Lanza F, Bregni M.
High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation.
Int J Gynecol Cancer. 2017 Feb;27(2):248-251.

224.
Huenecke S, Cappel C, Esser R, Pfirrmann V, Salzmann-Manrique E, Betz S, Keitl E, Banisharif-Dehkordi J, Bakhtiar S, Königs C, Jarisch A, Soerensen J, Ullrich E, Klingebiel T, Bader P, Bremm M.
Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.
Front Immunol. 2017 Feb 10;8:109.

223.
Bremm M, Cappel C, Erben S, Jarisch A, Schumm M, Arendt A, Bonig H, Klingebiel T, Koehl U, Bader P, Huenecke S.
Generation and flow cytometric quality control of clinical-scale TCRαβ/CD19-depleted grafts.
Cytometry B Clin Cytom. 2017 Mar;92(2):126-135.

222.
Fischer K, Tognarelli S, Roesler S, Boedicker C, Schubert R, Steinle A, Klingebiel T, Bader P, Fulda S, Ullrich E.
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells.
Front Immunol. 2017 Mar 7;8:202.

221.
von Stackelberg A, Locatelli F, Zugmaier G, Handgretinger R, Trippett TM, Rizzari C, Bader P, O'Brien MM, Brethon B, Bhojwani D, Schlegel PG, Borkhardt A, Rheingold SR, Cooper TM, Zwaan CM, Barnette P, Messina C, Michel G, DuBois SG, Hu K, Zhu M, Whitlock JA, Gore L.
Phase I/Phase II Stud of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
J Clin Oncol. 2016 Dec 20;34(36):4381-4389.

220.
von Stackelberg A, Locatelli F, Zugmaier G, Handgretinger R, Trippett TM, Rizzari C, Bader P, O'Brien MM, Brethon B, Bhojwani D, Schlegel PG, Borkhardt A, Rheingold SR, Cooper TM, Zwaan CM, Barnette P, Messina C, Michel G, DuBois SG, Hu K, Zhu M, Whitlock JA, Gore L.
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
J Clin Oncol. 2016 Dec 20;34(36):4381-4389.

219.
Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Simões BP, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M.
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
Blood. 2016 Dec 13. pii: blood-2016-10-745711. Epub ahead of print

218.
Lucchini G, Labopin M, Beohou E, Dalissier A, Dalle JH, Cornish J, Zecca M, Samarasinghe S, Gibson B, Locatelli F, Bertrand Y, Abdel-Rahman F, Socie G, Sundin M, Lankester A, Sedlacek P, Hamladji RM, Heilmann C, Afanasyev B, Hough R, Peters C, Bader P, Veys P.
Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant. 2017 Mar;23(3):467-474.

217.
Oelsner S, Friede ME, Zhang C, Wagner J, Badura S, Bader P, Ullrich E, Ottmann OG, Klingemann H, Tonn T, Wels WS.
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
Cytotherapy. 2016 Nov 22. pii: S1465-3249(16)30569-2. doi: 10.1016/j.jcyt.2016.10.009. Epub ahead of print

216.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M. .
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2017 Feb;52(2):191-196.

215.
Michel G, Cunha R, Ruggeri A, O'Brien TA, Bittencourt H, Dalle JH, Locatelli F, Iori AP, Mauad M, Oudin C, Giannotti F, Volt F, Gluckman E, Bader P, Rocha V.
Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification.
Leukemia 2016, 30 (5): 1180-3

214.
Huezo-Diaz Curtis P, Uppugunduri CR, Muthukumaran J, Rezgui MA, Peters C, Bader P, Duval M, Bittencourt H, Krajinovic M, Ansari M.
Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation.
Pharmacogenomics J. 2016 Oct 25. doi: 10.1038/tpj.2016.65. Epub ahead of print

213.
Ruggeri A, Volt F, Locatelli F, Michel G, Diaz de Heredia C, Abecasis M, Zecca M, Vora A, Yakouben K, O'Brien TA, Giardino S, Cornish J, Rocha V, Peters C, Bader P, Gluckman E, Dalle JH.
Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis.
Biol Blood Marrow Transplant. 2017 Jan;23(1):96-102.

212.
Cappel C, Huenecke S, Suemmerer A, Erben S, Rettinger E, Pfirrmann V, Heinze A, Zimmermann O, Klingebiel T, Ullrich E, Bader P, Bremm M.
Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
Pediatr Blood Cancer. 2016 Dec;63(12):2230-2239.

211.
Becker PS, Paranikulangara P, Rettinger E, Bader P, Seidl C.
The novel HLA-C*15:103 is characterised by an amino acid substitution in the alpha 2 domain.
HLA. 2016 Nov;88(5):267-268.

210.
Rettinger E, Merker M, Salzmann-Manrique E, Kreyenberg H, Krenn T, Dürken M, Faber J, Huenecke S, Cappel C, Bremm M, Willasch A, Bakhtiar S, Jarisch A, Soerensen J, Klingebiel T, Bader P.
Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation.
Biol Blood Marrow Transplant. 2017 Jan;23(1):87-95.

209.
Lucchini G, Willasch AM, Daniel J, Soerensen J, Jarisch A, Bakhtiar S, Rettinger E, Brandt J, Klingebiel T, Bader P.
Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study.
Pediatr Transplant. 2016 Dec;20(8):1132-1136.

208.
Bakhtiar S, Ruemmele F, Charbit-Henrion F, Lévy E, Rieux-Laucat F, Cerf-Bensussan N, Bader P, Paetow U.
Atypical Manifestation of LPS-Responsive Beige-Like Anchor Deficiency Syndrome as an Autoimmune Endocrine Disorder without Enteropathy and Immunodeficiency.
Front Pediatr. 2016 Sep 14;4:98. doi: 10.3389/fped.2016.00098.

207.
Willasch AM, Salzmann-Manrique E, Krenn T, Duerken M, Faber J, Opper J, Kreyenberg H, Bager R, Huenecke S, Cappel C, Bremm M, Pfirrmann V, Merker M, Ullrich E, Bakhtiar S, Rettinger E, Jarisch A, Soerensen J, Klingebiel TE, Bader P.
Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience.
Bone Marrow Transplant. 2016, 1-8.

206.
Bremm M, Huenecke S, Zimmermann O, Pfirrmann V, Quaiser A, Bonig H, Soerensen J, Klingebiel T, Rettinger E, Bader P, Cappel C.
In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy.
J Transl Med. 2016 Sep 13;14:264. doi: 10.1186/s12967-016-1024-4.

205.
Thiel U, Wawer A, von Luettichau I, Bender HU, Blaeschke F, Grunewald TG, Steinborn M, Röper B, Bonig H, Klingebiel T, Bader P, Koscielniak E, Paulussen M, Dirksen U, Juergens H, Kolb HJ, Burdach SE.
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
Oncotarget. 2016 Oct 25;7(43):70959-70968.
204.
Hartz B, Marsh R, Rao K, Henter JI, Jordan M, Filipovich L, Bader P, Beier R, Burkhardt B, Meisel R, Schulz A, Winkler B, Albert MH, Greil J, Karasu G, Woessmann W, Corbacioglu S, Gruhn B, Holter W, Kühl JS, Lang P, Seidel MG, Veys P, Löfstedt A, Ammann S, Ehl S, Janka G, Müller I, Lehmberg K.
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.
Blood. 2016 Jun 23;127(25):3281-90.

203.
Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E.
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant. 2016 Jul;51(7):906-12.

202.
Oelsner S, Wagner J, Friede ME, Pfirrmann V, Genßler S, Rettinger E, Buchholz CJ, Pfeifer H, Schubert R, Ottmann OG, Ullrich E, Bader P, Wels WS.
CAR-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-ALL and enhance survival.
Int J Cancer. 2016 Jun 2. doi: 10.1002/ijc.30217. Epub ahead of print

201.
Huenecke S, Bremm M, Cappel C, Esser R, Quaiser A, Bonig H, Jarisch A, Soerensen J, Klingebiel T, Bader P, Koehl U.
Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation.
Transfusion. 2016 Jun 27. doi: 10.1111/trf.13694. Epub ahead of print

200.
Bresters D, Lawitschka A, Cugno C, Pötschger U, Dalissier A, Michel G, Vettenranta K, Sundin M, Al-Seraihy A, Faraci M, Sedlacek P, Versluys AB, Jenkins A, Lutz P, Gibson B, Leiper A, Diaz MA, Shaw PJ, Skinner R, O'Brien TA, Salooja N, Bader P, Peters C.
Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.
Bone Marrow Transplant. 2016 Jun 27. doi: 10.1038/bmt.2016.139. Epub ahead of print

199.
Buxmann H, Reitter A, Bapistella S, Stürmer M, Königs C, Ackermann H, Louwen F, Bader P, Schlößer RL, Willasch AM.
Maternal CD4+ microchimerism in HIV-exposed newborns after spontaneous vaginal delivery or caesarean section.
Early Hum Dev. 2016 Jun 25;98:49-55. doi: 10.1016/j.earlhumdev.2016.06.004. Epub ahead of print

198.
Gerstner S, Köhler W, Heidkamp G, Purbojo A, Uchida S, Ekici AB, Heger L, Luetke-Eversloh M, Schubert R, Bader P, Klingebiel T, Koehl U, Mackensen A, Romagnani C, Cesnjevar R, Dudziak D, Ullrich E.
Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
J Leukoc Biol. 2016 Jun 28. pii: jlb.1A0116-038R. Epub ahead of print

197.
Schmidt K, Senn-Malashonak A, Wallek S, Rosenhagen A, Vogt L, Siegler K, Jung M, Bader P, Banzer WE.
Inpatient Exercise Therapy Versus Relaxation And Mental Training In Pediatric Stem Cell Transplantation: Results Of A Rct
Med Sci Sports Exerc. 2016 May;48(5 Suppl 1):518. doi: 10.1249/01.mss.0000486559.54451.02.

196.
Kuci Z, Bönig H, Kreyenberg H, Bunos M, Jauch A, Janssen JW, Skific M, Michel K, Eising B, Lucchini G, Bakhtiar S, Greil J, Lang P, Basu O, von Luettichau I, Schultz A, Sykora KW, Jarisch A, Soerensen J, Salzmann-Manrique E, Seifried E, Klingebiel T, Bader P, Kuci S.
Mesenchymal stromal cells generated from pooled mononuclear cells of multiple bone marrow donors as a rescue therapy for children with severe steroid-refractory graft versus host disease: a multicenter survey.
Haematologica. 2016 May 12. pii: haematol.2015.140368. Epub ahead of print

195.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M.
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
Bone Marrow Transplant. 2016 Jun;51(6):786-92.

194.
Preuner S, Peters C, Pötschger U, Daxberger H, Fritsch G, Geyeregger R, Schrauder A, von Stackelberg A, Schrappe M, Bader P, Ebell W, Eckert C, Lang P, Sykora KW, Schrum J, Kremens B, Ehlert K, Albert MH, Meisel R, Lawitschka A, Mann G, Panzer-Grümayer R, Güngör T, Holter W, Strahm B, Gruhn B, Schulz A, Woessmann W, Lion T.
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia.
Haematologica. 2016, 101 (4):741-6.

193.
Niederwieser C, Starke S, Fischer L, Krahl R, Beck J, Gruhn B, Ebell W, Körholz D, Wößmann W, Bader P, Lang P, Al-Ali HK, Cross M, Eisfeld AK, Heyn S, Vucinic V, Franke GN, Lange T, Pönisch W, Behre G, Christiansen H.
Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.
Ann Hematol. 2016 Feb;95(3):473-81.

192.
Baronciani D, Angelucci E, Potschger U, Gaziev J, Yesilipek A, Zecca M, Orofino MG, Giardini C, Al-Ahmari A, Marktel S, de la Fuente J, Ghavamzadeh A, Hussein AA, Targhetta C, Pilo F, Locatelli F, Dini G, Bader P, Peters C.
Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.
Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.293. Epub ahead of print

191.
Becker PS, Suck G, Nowakowska P, Ullrich E, Seifried E, Bader P, Tonn T, Seidl C.
Selection and expansion of natural killer cells for NK cell-based immunotherapy.
Cancer Immunol Immunother. 2016, 65(4):477-84.

190.
Pietzner J, Merscher BM, Baer PC, Duecker RP, Eickmeier O, Fußbroich D, Bader P, Del Turco D, Henschler R, Zielen S, Schubert R.
Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.
Bone Marrow Transplant. 2016 Apr; 51(4):619.

189.
Rettinger E, Huenecke S, Bonig H, Merker M, Jarisch A, Soerensen J, Willasch A, Bug G, Schulz A, Klingebiel T, Bader P.
IL-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy.
Haematologica. 2016 Jan 14. pii: haematol.2015.138016. Epub ahead of print.

188.
Nierkens S, Lankester AC, Egeler RM, Bader P, Locatelli F, Pulsipher MA, Bollard CM, Boelens JJ; Westhafen Intercontinental Group.
Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients.
Cytotherapy. 2015 Dec;17(12):1667-74.Dec;17(12):1667-74. Review.

187.
Jacobs B, Tognarelli S, Poller K, Bader P, Mackensen A, Ullrich E.
NK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation.
Front Immunol. 2015 Nov 24;6:583. doi: 10.3389/fimmu.2015.00583. eCollection 2015.

186.
C Dufour, P Veys, E Carraro, N Bhatnagar, M Pillon, R Wynn, B Gibson, AJ Vora,
CG Steward, AM Ewins, RE Hough, J de la Fuente, M Velangi, PJ Amrolia, R Skinner,
A Bacigalupo, AM Risitano, G Socie, R Peffault de Latour, J Passweg, A Rovo,
A Tichelli, H Schrezenmeier, B Hochsmann, P Bader, A van Biezen, MD Aljurf,
A Kulesekararaj, JC Marsh, S Samarasinghe.
Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Br J Haematol. 2015 Jul 28. doi: 10.1111/bjh.13614. Epub ahead of print PubMed PMID:26223288.

185.
A Kruchen, T Stahl, F Gieseke, TM Binder, Z Özcan, R Meisel, H Kreyenberg, P Bader , B Gruhn, J Greil, M Pfeiffer, M Döring, R Handgretinger, B Fehse, I Müller.
Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients.
Bone Marrow Transplant. 2015 Jun 22. doi: 10.1038/bmt.2015.136. Epub ahead of print No abstract available.

184.
V Pfirrmann, S Oelsner, E Rettinger, S Huenecke, H Bonig, M Merker, WS Wels, K Cinatl, R Schubert, T Klingebiel, P Bader.
Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus.
Cytotherapy. 2015 Aug; 17(8):1139-51

183.
A Koltze, P Rath, S Schöning, J Steinmann, TA Wichelhaus, P Bader, K Bochennek, T Lehrnbecher.
Beta-D-Glucan Screening for the Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
J Clin Microbiol. 2015 Aug;53(8):2605-10.

182.
MM Chao, W Ebell, P Bader, R Beier, B Burkhardt, T Feuchtinger, R Handgretinger, H Hanenberg, U Koehl, C Kratz, B Kremens, P Lang, R Meisel, I MuellerI, C Roessig, M Sauer , PG Schlegel, A Schulz, B Strahm, F Thol, KW Sykora.
Consensus of German Transplant Centers on Hematopoietic Stem Cell Transplantation in Fanconi Anemia.
Klin Padiatr. 2015 May;227(3):157-165

181.
M Bunos, C Hümmer, E Wingenfeld, N Sorg, V Pfirrmann, P Bader, E Seifried, H Bönig.
Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise.
Vox Sang. 2015 May 7. doi: 10.1111/vox.12291. Epub ahead of print

180.
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, P Bader, F Baron, A Bazarbachi, D Blaise, F Ciceri, S Corbacioglu, JH Dalle, RF Duarte, T Fukuda, A Huynh, T Masszi, M Michallet, A Nagler, ;M NiChonghaile, T Pagluica, C Peters, FB Petersen, PG Richardson, T Ruutu, BN Savani, E Wallhult, I Yakoub-Agha, E Carreras.
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2015 Jun;50(6):781-9.

179.
A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, JH Falkenburg, D Farge-Bancel, A Gennery, N Kröger, F Lanza, JC Marsh, A Nagler, C Peters, A Velardi, M Mohty, A Madrigal.
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.
Bone Marrow Transplant. 2015 Mar 23. doi: 10.1038/bmt.2015.6. Epub ahead of print

178.
C Peters, M Schrappe, A von Stackelberg, A Schrauder, P Bader, W Ebell, P Lang, KW Sykora, J Schrum, B Kremens, K Ehlert, MH Albert, R Meisel, S Matthes-Martin, T Gungor, W Holter, B Strahm, B Gruhn, A Schulz, W Woessmann, U Poetschger, M Zimmermann, T Klingebiel.
Stem-Cell Transplantation in Children With Acute Lymphoblastic Leukemia: A Prospective International Multicenter Trial Comparing Sibling Donors With Matched Unrelated Donors-The ALL-SCT-BFM-2003 Trial.
J Clin Oncol. 2015, 33(11):1265-74.

177.
JR Passweg, H. Baldomero, P. Bader, C. Bonini, S. Cesaro, P. Dreger, RF Duarte,
C. Dufour, JH Falkenburg, D. Farge-Bancel, A. Gennery, N. Kröger, F. Lanza, A. Nagler,
A. Sureda, M. Mohty.
[f:Hematopoietic SCT in Europe 2013: recent trends in the use of
alternative donors showing more haploidentical donors but fewer cord blood transplants.]
Bone Marrow Transplant. 2015, 50(4):476-82.

176.
J. Feucht, K. Opherk, P. Lang, S. Kayser, L. Hartl, W. Bethge, S. Matthes-Martin, P. Bader, MH Albert, B. Maecker-Kolhoff, J. Greil, H. Einsele, PG Schlegel, FR Schuster, B. Kremens, C. Rossig, B. Gruhn, R. Handgretinger, T. Feuchtinger.
Adoptive T-cell therapy with hexon-specific THELPER-1 cells as a treatment for refractory adenovirus infection after HSCT.
Blood. 2015 Jan 23. pii: blood-2014-06-573725. Epub ahead of print

175.
A. Lawitschka, M. Faraci, I Yaniv, P Veys, P. Bader, J. Wachowiak, G. Socie, MD Aljurf, M. Arat, JJ Boelens, R. Duarte, A. Tichelli, C. Peters. Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP.
Bone Marrow Transplant. 2015 Jan 26. doi: 10.1038/bmt.2014.306. Epub ahead of print

174.
P. Bader, H. Kreyenberg, A. von Stackelberg, C. Eckert, E. Salzmann-Manrique, R. Meisel, U. Poetschger, D. Stachel, M. Schrappe, J. Alten, A. Schrauder, A. Schulz, P. Lang, I. Müller, MH Albert, AM Willasch, TE Klingebiel, C. Peters.
Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial.
Journal of Clinical Oncology, 2015 Jan 20. pii: JCO.2014.58.4631. Epub ahead of print

173.
A. Jarisch, CG Steward CG, J. Sörensen, L. Porto, M. Kieslich,T. Klingebiel, P.Bader.
Odontoid infiltration and spinal compression in Farber Disease: reversal by haematopoietic stem cell transplantation.
Eur J Pediatr, 2014, 173 (10): 1399-403

172.
M. Döring, KM Cabanillas Stanchi, S. Haufe, A. Erbacher, P. Bader, R. Handgretinger, M-Hofbeck, G. Kerst.
Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation.
Ann Hematol. 2014 Dec 30. Epub ahead of print

171.
D. Steinbach, P. Bader, A. Willasch, S. Bartholomae, KM Debatin, M. Zimmermann, U. Creutzig, D. Reinhardt, B. Gruhn.
Prospective validation of a new method of monitoring minimal residual disease in childhood acute myeloid leukemia.
Clin Cancer Res. 2014 Dec 11. pii: clincanres.1999.2014. Epub ahead of print

170.
MC Elze, O. Ciocarlie, A. Heinze, S. Kloess, T. Gardlowski, R. Esser, T. Klingebiel, P. Bader, S. Huenecke, M. Serban, U. Köhl, JL Hutton.
Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation.
Bone Marrow Transplant. 2014 Nov 10. doi: 10.1038/bmt.2014.257. Epub ahead of print

169.
M. Döring, KM Rohrer, A. Erbacher, F. Gieseke, CP Schwarze, P. Bader, R. Handgretinger, M. Hofbeck, G. Kerst.
Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation.
Ann Hematol. 2014 Aug 13. Epub ahead of print

168.
E. Rettinger, A. Glatthaar, BA Abhari, S. Oelsner, V. Pfirrmann, S. Huenecke, S. Kuçi, H. Kreyenberg, AM Willasch, T. Klingebiel, S. Fulda, P. Bader.
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.
Front Pediatr. 2014 Jul 18;2:75. doi: 10.3389/fped.2014.00075. eCollection 2014

167.
AM Willasch, H. Kreyenberg, N. Shayegi, E. Rettinger, V. Meyer, M. Zabel, P. Lang, B. Kremens, R. Meisel, B. Strahm, C. Rossig, B. Gruhn, T. Klingebiel, CM Niemeyer, P. Bader.
Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or bone marrow?
Biol Blood Marrow Transplant. 2014;20(12):1918-25.

166.
AC Lankester, F. Locatelli, P. Bader, E. Rettinger, M. Egeler, S. Katewa, MA Pulsipher,
S. Nierkens, K. Schultz, R. Handgretinger, SA Grupp, JJ Boelens, CM Bollard; Westhafen Intercontinental Group.
Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?
Biol Blood Marrow Transplant. 2014 Jul 23. pii: S1083-8791(14)00444-3. Review.

165.
C. Brehm, S. Huenecke, R. Esser, S. Kloess, A. Quaiser, S. Betz, O. Zimmermann, J. Soerensen, JR Passweg, T. Klingebiel, D. Schwabe, P. Bader, U. Koehl.
Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy.
Cancer Immunol Immunother. 2014;63(8):821-33

164.
A. Balan, G. Lucchini, S. Schmidt, A. Schneider, L. Tramsen, S. Kuçi, R. Meisel, P. Bader, T. Lehrnbecher.
Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease-friends or foes?
Leukemia. 2014; 28(10):1941-8

163.
E. Rettinger, H. Kreyenberg, M. Merker, S. Kuçi, A. Willasch, G. Bug, E. Ullrich, WS Wels, H. Bonig, T. Klingebiel, P. Bader.
Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion.
Cytotherapy. 2014 Feb 27. pii: S1465-3249(14)00023-1. doi: 10.1016/j.jcyt.2014.01.003. Epub ahead of print

162.
G. Lucchini, P. Bader.
Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge.
Expert Rev Hematol. 2014; 7(2):291-300.